Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 18 (2017)

Articles

NEWS OF MEDICINE

- -.
Pharmateca. 2017;(18):4-7
pages 4-7 views

Case of the combined application of cognitive-behavior therapy and zopiclone in chronic insomnia

Tsenteradze S.L., Poluektov M.G., Pchelina P.V.

Abstract

Insomnia is characterized by the difficulties in falling asleep and sleep maintenance, and various types of disorders of day-to-day functioning. «Insomnia» both as a symptom and as disease has serious professional and social consequences, affecting daytime activity and professional abilities. The main role in the pathogenesis of insomnia is played by the state of cerebral hyperactivation, which has cognitive, electrophysiological and metabolic manifestations. The method of choice in the treatment of most forms of insomnia is cognitive-behavioral therapy. Third generation hypnotics are the most common pharmacological treatments for insomnia, and zopiclone occupies one of the leading places among them.
Pharmateca. 2017;(18):8-13
pages 8-13 views

Pelvic varicies as a cause of the syndrome of chronic pain

Fomin V.S., Fomina M.N.

Abstract

Pelvic vein incompetence is often associated with typical clinical signs of congestion as well as pelvic pain. This clinical entity is often underestimated and patients suffering from pain related to pelvic varicosities undergo a long and inconclusive diagnostic workup before the exact cause of symptoms is recognized. This article reviews currently available diagnostic, therapeutic and surgical options.
Pharmateca. 2017;(18):14-19
pages 14-19 views

Initial antibacterial therapy for the treatment of acute otitis media in pediatric practice

Kryukov A.I., Kunelskaya N.L., Ivoylov A.Y., Arkhangelskaya I.I.

Abstract

Acute otitis media (AOM) is one of the most common diseases in children and is one of the reasons for the appointment of systemic antibacterial therapy. Taking into account typical pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) and Russian data on antibiotic resistance, the drug of first choice in AOM is amoxicillin, which has a high stable activity against the abovementioned major bacterial pathogens. Due to the high level of resistance of pneumococcus to penicillins in many countries of the world, it is recommended to use high doses of the drug (80-90 mg/kg/day), which create concentrations exceeding the MIC for strains with an intermediate level of resistance. The tactics and duration of antibacterial therapy in case of AOM are discussed.
Pharmateca. 2017;(18):20-24
pages 20-24 views

Triple combinations of antianginal preparations in the treatment of stable effort stenocardia in elderly and senile patients

Kanorsky S.G., Smolenskaya N.V.

Abstract

A prospective, randomized study of the efficacy and safety of antianginal therapy using combinations of bisoprolol, ivabradine and trimetazidine or ranolazine at the age 60 to 79 years included 107 patients with coronary artery disease and grade II/III stable effort angina. In case of retention of angina and/or painless myocardial ischemia against the background of use of bisoprolol and ivabradine after randomization, patients were additionally prescribed with trimetazidine (35 mg twice a day, n=54) or ranolazine (500 mg twice a day, n=53). Within 6 months, both methods of treatment were well tolerated, significantly improved the results of the treadmill tesT., the left ventricular systolic and diastolic functions, the structural and functional state of large arteries, and the quality of life of patients. Trimetazidine significantly reduced the duration of painless ST-segment depression according to Holter ECG monitoring. Combinations of low-dose ß-blocker with ivabradine and trimetazidine or ranolazine can be used in the treatment of refractory stable angina in elderly and senile patients.
Pharmateca. 2017;(18):25-31
pages 25-31 views

Experience of the use of cytoprotec-tor rebamipide in the treatment of nsaid-induced erosive gastropathy

Sivokhina T.A., Kozhina M.V.

Abstract

The article presents the results of the evaluation of the effectiveness of rebambide in the treatment of erosive gastropathy, which arose as a result of the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Comparative analysis showed that rebamipide stimulates the synthesis of prostaglandins and mucus glycoproteins in the mucous membrane of the gastrointestinal tracT., increases the expression of the epidermal growth factor and its receptors, reduces the production of pro-inflammatory cytokines and free radicals, which contributes to the rapid regeneration of erosive changes in the stomach. Thus, rebamipide is a drug of choice in preventing the development of NSAID-induced gastrointestinal complications.
Pharmateca. 2017;(18):32-35
pages 32-35 views

Compression changes of vertebral bodies in patients with axial spon-diloarthritis, including ankilosing spondylitis

Gaydukova I.Z., Dorogoykina K.D., Akulova A.I., Mysin M.A., Rebrov A.P.

Abstract

The evaluation of changes in the musculoskeletal system in patients with axial spondyloarthritis (axSpA) seems to be a relevant task. The article presents the results of study aimed to the determine the occurrence and features of deformations of the vertebral bodies in patients with AxSpA by assessment of spine X-rays and to compare the results with the frequency of decrease in bone mineral density (BMD) assessed by dual energy X-ray absorptiometry (DEXA). According to the results of the study, patients with axSpA showed a high occurrence of changes in the shape of vertebral bodies and a decrease in BMD. Each fifth patient with axSpA has changes in the shape of vertebral bodies with normal BMD. Thus, in order to form a full-fledged characterization of the state of the axial skeleton and adequate correction of the treatment of patients, combined use of the X-ray examination of the spinal column and DEXA is required.
Pharmateca. 2017;(18):36-40
pages 36-40 views

Left ventricle dysfunction and its determinants in patients with ST-segment elevation acute myocardial infarction

Lebedev P.A., Verbovoy A.F., Mateesku K.A., Aleksandrov M.Y., Povalayeva R.A.

Abstract

The article discusses the echocardiographic parameters characterizing the violation of contractility and diastolic properties of the left ventricular myocardium in patients with ST-segment elevation acute myocardial infarction evaluated in a prospective study. In case of effective revascularization and thrombolysis, the prevalence of diastolic dysfunction with a preserved or moderately reduced systolic dysfunction is observed. Under these conditions, the use of the widespread parameter of the left ventricular ejection fraction, which characterizes the degree of shortening of the myocardial fibers, is not informative. Tissue dopplerography of the mitral annulus makes it possible to evaluate the global contractility of the left ventricle and its diastolic properties. The closest significant correlations with the determinants of myocardial damage (markers of necrosis and inflammatory activity) were obtained for the myocardial performance index, which justifies the clinical value of this index as an integral parameter that reliably reflects both types of myocardial dysfunction.
Pharmateca. 2017;(18):41-46
pages 41-46 views

Dance therapy in Parkinson’s disease

Gubanova E.N., Fedorova N.V., Bril E.V.

Abstract

The article presents the results of the evaluation of the effect of dance therapy on motor, cognitive and affective disorders, the quality of life and the daily activity of patients with Parkinson’s disease. It is shown that music classes combined with dances are an effective method of non-pharmacological therapy and rehabilitation of patients with Parkinson’s disease.
Pharmateca. 2017;(18):47-49
pages 47-49 views

Diurethic resistance: mechanisms, medical tactics and prevention

Dyadyk A.I., Kugler T.E., Schukina E.V., Rakitskaya I.V., Zborovsky S.R., Suliman Y.V.

Abstract

Diuretics play an important role in modern clinical practice due to their unique mechanisms of action and ability to influence many pathological processes. This review focuses on the achievements and problems of diuretic therapy. Among the unsolved problems, particular attention should be paid to the development of «diuretic resistance», the frequency of which reaches 20-30% of cases. The leading reasons for the development of diuretic resistance in pathological conditions that occur with systemic edema, in particular, heart failure, chronic kidney disease and nephrotic syndrome, are discussed. During diuretic therapy, along with the characteristics of the pathological condition, it is necessary to take into account such parameters of pharmacokinetics as bioavailability, metabolic pathways and half-life, which play a key role in choosing a class of diuretics, their dosages and route of administration. Treatment approaches aimed at overcoming diuretic resistance and its prevention include «natriuretic» and «non-natriuretic» strategies, as well as ultrafiltration.
Pharmateca. 2017;(18):50-56
pages 50-56 views

Iron-deficiency states in practice of a therapist

Bunova S.S.

Abstract

Iron refers to irreplaceable trace elements, the regular intake of which is absolutely necessary for the normal functioning of all living organisms in an oxygen environment. The biological role of iron is high and is determined by its participation in oxidation-reduction processes, the reactions of oxygen-dependent free radical oxidation and the antioxidant system, the growth and aging of tissues, the mechanisms of general and tissue resistance, hemopoiesis, the supply of organs and tissues with oxygen, activation and inhibition of a number of enzymes. Many metabolic processes occur with the participation of iron: synthesis of steroids, metabolism of drugs, DNA synthesis, proliferation and differentiation of cells, regulation of genes. Therefore, even the prelatent and latent iron deficiency in the body affects to some extent the processes listed above and affects all levels: genetic, molecular, cellular, tissue, organ, systemic and requires immediate replenishment.
Pharmateca. 2017;(18):57-62
pages 57-62 views

Long-term complex therapy of cardiovascular diseases (reduction of cardiovascular risk: hypolidemic and antihypertensive therapy). Combined preparations as a method of increasing treatment adherence

Fofanova T.V., Ageyev F.T., Smirnova M.D.

Abstract

The treatment of cardiovascular diseases continues to be an important public health problem. Antihypertensive, lipid-lowering, anti-diabetic and antiplatelet therapies are intended to significantly reduce the risk of cardiovascular complications and fatal events. In real clinical practice, however, the effectiveness of the preventive measures is insufficient. Despite the availability of new drugs, the treatment of cardiovascular diseases remains suboptimal. The high prevalence of people with multiple risk factors requires the use of treatment tactics based on a combination of drugs against various risk factors. Simplification of treatment regimen, the use of fixed-dose combinations, is one of the facets of increasing treatment adherence, which causes an increase in the effectiveness of long-term therapy.
Pharmateca. 2017;(18):63-70
pages 63-70 views

Relevance of neurological assistance in the management of patients with Parkinson’s disease

Bril E.V., Fedorova N.V., Kulua T.K., Zimnyakova O.S., Anikina M.A.

Abstract

The article presents a review devoted to the relevance of the neurological examination of patients with Parkinson’s disease (PD), as well as the most common causes of error diagnosis of PD, the reasons for hospitalization and mortality in PD.
Pharmateca. 2017;(18):71-75
pages 71-75 views

Cardiovascular toxicity of fluoropirymidines

Kolomiets E.A., Besova N.S., Kurmukov I.A., Kashia S.R., Narimanov M.N., Sandomirskaya A.P.

Abstract

Cardiovascular toxicity of fluoropyrimidines is revealed in 1-19% of patients. Its frequency consistently increases with the administration of large single doses and long-term infusions, in case of combination with bevacizumab and platinum preparations; with concomitant coronary artery disease, in former smokers. Due to multiple pathophysiological mechanisms of damage to the heart and vessels, the manifestations of cardiovascular toxicity are diverse. The severity of the damage varies from asymptomatic changes in the electrocardiogram and arrhythmia to acute coronary syndrome and sudden death. The review describes the diagnostic algorithm and possible approaches to the treatment and prevention of repeated cardiovascular events associated with the use of fluoropyrimidines.
Pharmateca. 2017;(18):76-79
pages 76-79 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies